When DNA in cancer cells comes off chromosomes, “extrachromosomal DNA (ecDNA),” it becomes unbound and unwound, thereby enabling numerous copies of cancer-causing genes, driving cancer cells to grow and allowing them to resist treatment. At Boundless Bio, we are counterattacking this ecDNA phenomenon with boundless innovation and boundless energy to develop powerful new cancer medicines that eliminate cancer cells’ ability to employ ecDNA to survive.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Currently not disclosed
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):